Direkt zum Inhalt
Merck
  • Cecal perforation associated with sodium polystyrene sulfonate-sorbitol enemas in a 650 gram infant with hyperkalemia.

Cecal perforation associated with sodium polystyrene sulfonate-sorbitol enemas in a 650 gram infant with hyperkalemia.

American journal of perinatology (1996-04-01)
L N Bennett, T F Myers, G H Lambert
ZUSAMMENFASSUNG

We report a 650 g, 24 week hyperkalemic newborn who developed both cecal impaction and perforation after treatment with sodium polystyrene sulfonate enemas. Flat plate abdominal radiographs revealed impacted resin as a radiodense material outlining the bowel. Pathological examination showed sodium polystyrene sulfonate crystals contained in the cecal abscess. Review of the literature in both adults and children leads us to conclude that the use of this sodium-potassium exchange resin for the treatment of hyperkalemia in this gestational age group is probably not helpful for decreasing serum potassium and may be detrimental to the infant.

MATERIALIEN
Produktnummer
Marke
Produktbeschreibung

Sigma-Aldrich
D-Sorbit, ≥98% (GC)
Sigma-Aldrich
D-Sorbit, BioUltra, ≥99.0% (HPLC)
Sigma-Aldrich
D-Sorbit, 99% (GC)
Sigma-Aldrich
D-Sorbit, ≥98% (GC), Molecular Biology
Supelco
Sorbit, Pharmaceutical Secondary Standard; Certified Reference Material
USP
Sorbit, United States Pharmacopeia (USP) Reference Standard
Sigma-Aldrich
D-Sorbit, ≥98% (GC), BioReagent, suitable for cell culture, suitable for plant cell culture
Sorbit, European Pharmacopoeia (EP) Reference Standard
Sigma-Aldrich
Sorbit F -Lösung, 70 wt. % in H2O, Contains mainly D-sorbitol with lesser amounts of other hydrogenated oligosaccharides
Sigma-Aldrich
D-Sorbit, ≥98% (GC), BioXtra
Sigma-Aldrich
D-Sorbit, FCC, FG
Sigma-Aldrich
D-Sorbit, liquid, tested according to Ph. Eur.